| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 09/18/2008 | US20080227765 Cytotoxic depsipeptides |
| 09/18/2008 | US20080227725 Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080226716 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 09/18/2008 | US20080226550 Mercaptan containing diagnostic agents for imaging malignant melanoma and distant metastases and rhenium (186Re, 188Re) therapeutic complexes for treating the same |
| 09/17/2008 | EP1968999A2 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins |
| 09/17/2008 | EP1968645A2 Human glp-1 mimetibodies and compositions for treating obesity and related disorders, methods and uses |
| 09/17/2008 | EP1392639B1 Pyruvate derivatives |
| 09/17/2008 | CN101268093A Age inhibitors |
| 09/17/2008 | CN101267829A Thrombospondin-1 derived peptides and treatment methods |
| 09/16/2008 | US7425612 Ring finger protein 43 for use as diagnostic indicator of cell proliferative disorders; antitumor agents; RNA interference; drug screening |
| 09/16/2008 | US7425611 Immunogenic HIV-1 multi-clade, multivalent constructs and methods of their use |
| 09/16/2008 | US7425608 Combinatorial library of different sequence peptide members synthesized on solid phase, where each constituent library member includes peptide sequence of three or more amino acid residues bound to solid phase characterized by sequence of two or more amino acid residues forming a metal ion-binding domain |
| 09/16/2008 | US7425576 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis |
| 09/16/2008 | US7425541 Therapy of tumors; prodrugs that display a high specificity of action, a reduced toxicity, and an improved stability in blood |
| 09/16/2008 | US7425537 Macrocyclic peptide prevent binding with phosphoprotein; cancer therapy; angiogenesis inhibitor |
| 09/16/2008 | US7425333 Hypoallergenic allergy vaccines based on the timothy grass pollen allergen Phl p 7 |
| 09/16/2008 | CA2387738C Process for producing a product containing antihypertensive tripeptides |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/12/2008 | WO2008108285A1 Peptide |
| 09/12/2008 | WO2008107362A2 Stabiliser and inhibitors of factor vii |
| 09/11/2008 | US20080221181 Compounds for treating tumors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221038 Neuropeptide Y receptor antagonists and agonists including O-glycosylated tripeptides, O-glycopeptides, and extended tripeptides; cardiovascular disorders |
| 09/11/2008 | US20080220536 Tethering target having reactive thiol contacted with extender forming complex; conjugation; drug screening |
| 09/11/2008 | US20080220470 Protein hydrolysate rich in tripeptides |
| 09/11/2008 | US20080220093 Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells |
| 09/11/2008 | DE102006050091A1 Verfahren zur selektiven Lokalisierung von Wirkstoffen an und in Mitochondrien und entsprechende Wirkstoffe Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients |
| 09/10/2008 | EP1967524A1 Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby |
| 09/10/2008 | EP1966389A1 Enzyme measurement assay using a modified substrate comprising a substrate attached to a macromolecule via a spacer |
| 09/10/2008 | EP1966233A1 An oxidation process for the preparation of n-[3-amino-1- (cyclobutylmethyl)-2,3-dioxopropyl-3-{n-[(tert-butylamino)carbonyl]-3-methyl-l-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds |
| 09/10/2008 | EP1965650A2 Compositions and methods for attenuating mitochondria-mediated cell injury |
| 09/10/2008 | EP1474440B1 Coniosulphides and their derivatives, method for their production and use as medicaments |
| 09/10/2008 | CN101263156A Novel macrocyclic inhibitors of hepatitis C virus replication |
| 09/10/2008 | CN101261277A Promyostatin peptides and methods of using same |
| 09/09/2008 | US7423169 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs |
| 09/09/2008 | US7423116 Pentapeptide compounds and uses related thereto |
| 09/09/2008 | US7423115 Inducing an apoptosis or a killing of a cell, enhancing an effectiveness of cancer chemotherapy |
| 09/09/2008 | US7423114 GD2 ligands |
| 09/09/2008 | US7423058 Inhibitors of hepatitis C virus NS3 protease |
| 09/09/2008 | US7423007 Cxcr4 antagonist and use thereof |
| 09/09/2008 | US7422733 Antiinflammatory agents; anticancer agents; antidiabetic agents |
| 09/09/2008 | CA2252163C D-proline derivatives |
| 09/04/2008 | WO2008106130A2 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 09/04/2008 | WO2008106104A2 Environmentally sensitive fluorophores |
| 09/04/2008 | WO2008106080A2 Synthesis of desacetoxytubulysin h and analogs thereof |
| 09/04/2008 | WO2008104203A2 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | WO2008013935A3 Tyrosine phosphorylation sites |
| 09/04/2008 | US20080214782 Amino acid sequence phosphorylation site motif; structural variance and disease diagnosis |
| 09/04/2008 | US20080214648 Hiv Prodrugs Cleavable by Cd26 |
| 09/04/2008 | US20080214478 Small Peptides And Methods For Inhibiting The Infiltration Of Eosinophils Into Airways |
| 09/04/2008 | US20080214477 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting t-cell migration; immunotherapy |
| 09/04/2008 | US20080214476 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; inhibiting mucous release into airways of patients; immunotherapy |
| 09/04/2008 | US20080214475 Small Peptides And Methods For Inhibiting The Mucous Release Into Airways |
| 09/04/2008 | US20080214474 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease |
| 09/04/2008 | US20080214473 Using f-met-leu-x peptides to modify lymphocyte response to immunoglobulin-e challenge; treatment and prevention of respiratory system disorders; antiinflammatory agents; immunotherapy |
| 09/04/2008 | US20080214472 Small Peptides And Methods For Treatment Of Arthritis |
| 09/04/2008 | US20080214469 Novel Biologically Active Peptides and Their New Uses |
| 09/04/2008 | US20080214446 Gene Introduction Efficiency Enhancer |
| 09/04/2008 | US20080213898 Compositions and methods for nucleic acid delivery |
| 09/04/2008 | US20080213793 Antibodies that bind receptor protein designated 2f1 |
| 09/04/2008 | US20080213249 Conjugation; Fab fragments; for treatment of cancer metastasis |
| 09/04/2008 | US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome |
| 09/04/2008 | US20080213175 Radiolables with amide bond by a 1,4-disubstituted 1,2,3-triazole ("1,2,3-anti-triazole") preserves the cyclic peptides' functional and structural integrity while providing enhanced metabolic stability in vivo |
| 09/04/2008 | CA2679514A1 18f fluoro-benzoyl labelled biologically active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy-benzoyl and trimethylammonio-benzoyl precursers |
| 09/04/2008 | CA2679377A1 Tertiary amine substituted peptides useful as inhibitors of hcv replication |
| 09/04/2008 | CA2679312A1 Co-crystals and pharmaceutical compositions comprising the same |
| 09/03/2008 | EP1964849A2 Transfection complexes |
| 09/03/2008 | EP1964848A1 Radiofluorination methods |
| 09/03/2008 | EP1964836A2 A process for the preparation of perindopril erbumine in alpha crystalline form |
| 09/03/2008 | EP1963364A2 Compounds and methods for inhibiting apoptosis |
| 09/03/2008 | EP1963357A1 Compounds for the inhibition of apoptosis |
| 09/03/2008 | EP1771731A4 Detection of truncation mutations by mass spectrometry |
| 09/03/2008 | EP1684788B1 Peptide increasing fusiogenic capacity of a gamete |
| 09/03/2008 | EP1161455B1 A novel chimeric protein for prevention and treatment of hiv infection |
| 09/03/2008 | CN101255189A Animal vaccine immunopotentiator and production method thereof |
| 09/03/2008 | CN100415770C 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 09/02/2008 | US7420030 Mimetic amino acid sequences for use in prevention and treatment of cell proliferative disorders |
| 09/02/2008 | US7420002 Amino acid conjugates providing for sustained systemic concentrations of GABA analogues |
| 09/02/2008 | US7419970 Cosmetic compositions comprising N-acylamino amides |
| 09/02/2008 | US7419951 Administering a peptide |
| 09/02/2008 | US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization |
| 09/02/2008 | CA2397773C Universal procedure for refolding recombinant proteins |
| 09/02/2008 | CA2372053C Compositions and methods for cancer treatment by selectively inhibiting vegf |
| 08/28/2008 | WO2008104000A2 Triazole macrocycle systems |
| 08/28/2008 | WO2008103693A2 Chemical linkers with single amino acids and conjugates thereof |
| 08/28/2008 | WO2008102233A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 08/28/2008 | WO2008101665A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/28/2008 | WO2008010980A3 Tat-049 and methods of assessing and treating cancer |
| 08/28/2008 | US20080207668 Pharmaceutical compositions of hydromorphone for prevention of overdose or abuse |
| 08/28/2008 | US20080207528 Administering derivatives of 4-(3-pyrrolidinyloxy)quinoline |
| 08/28/2008 | US20080207527 Bicyclic isophthalamide derivatives such as N1-(5-hydroxy-8-(1-(isopropylamino)-3-methyl-1-oxobutan-2-ylamino)-2,7-dimethyl-8-oxooctan-4-yl)-5-(N-methylmethylsulfonamido)-N3-(1-phenylethyl)isophthalamide; Alzheimer's disease |
| 08/28/2008 | US20080207526 Synthetic peptides and methods of use for autoimmune disease therapies |
| 08/28/2008 | US20080206820 activated ester of the carboxyl-containing compound (carboxylic acid) is reacted with H217O or H218O in the presence of an activator; labelled amino acid |
| 08/28/2008 | US20080206230 Peptides Derived from Human Bplp Protein, Polynucleotides Coding for Said Peptides and Antibodies Directed Against Said Peptides |
| 08/28/2008 | CA2678941A1 Triazole macrocycle systems |
| 08/28/2008 | CA2678514A1 Chemical linkers with single amino acids and conjugates thereof |
| 08/28/2008 | CA2677843A1 Macrocyclic compounds as hcv ns3 protease inhibitors |
| 08/27/2008 | EP1961759A1 Integrin targeted cyclopeptide ligands, their preparation and use |
| 08/27/2008 | EP1960420A2 Novel compounds which interact with pea-15 |